Case File
efta-01887803DOJ Data Set 10OtherEFTA01887803
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01887803
Pages
3
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Eileen Alexanderso
From:
Jeffrey Epstein
Sent
Sun 9/30/2012 3:48:06 PM
Subject: Re: Fw: please see attached re our conversation later
if it is important to close tomorrow I would do as littel as possible and put it in a holding co . no
more no less. DO Not use trusts . in any capacity whatsover. I am trying to call leon
On Sun, Sep 30, 2012 at 11:19 AM, Eileen Alexanderson
wrote:
Update on the attached structure chart for our purchase of Phaidon by the Trusts: the
decision was to use a UK LLP instead of the Scottish one largely because the setup process(ie.
You need Scottish counsel and a Scottish registered address) is easier and the PWC man could
not convince all others that there was enough benefit. I've been advised there is a definite
advantage to having the trusts own this through LLCs instead of going directly in (as you read
in the email I forwarded from Gregor) and Leon will enter through a separate LLC than the
trusts and be the Managing Member. I'm just thinking through governance and who should be
on what Boards. The Trustees then would be the members of the LLP. Bidco will be buying
and own the shares of PPL. Since money for that is coming from the trusts I am thinking at
least one of the Trustees should be on this Board with Leon and Debra-correct? Leon wants
the kids themselves to be part of this too as a learning experience and as prep for one of them
potentially running this someday-I am thinking they should only be on the Board of PPL, the
actual company, Phaidon Press Ltd with the Exec Directors from company management and a
few additional outsiders Leon has in mind with Publishing expertise-or could/should they be
on the bidco board? I was advised board meetings of these UK cos need to take place in the
UK or you can jeopardize status as a UK company. Leon & Debra are there frequently, the
kids less so. Errors in my thought process so far?
I've also been thinking through your idea of Leon lending money to the trusts in the name of an
opportunity to forgive over time and thereby make gifts to the trust. One of the trusts owes
Leon $20mil. I was going to use $21 mil I now have on hand in that trust for the purchase. I
can first pay Leon back on the outstanding loan and then make a new loan if that makes sense.
Debra has $4mil left on her gift exemptio , Leon I believe has less than $2mil. Can I make he
loan and then forgive in December to use up the gift exemption, or is that too soon. If not,
how should I size the loan. $20mil just seems large unless you do the forgiving over a very
long period of time.
Thanks, sorry for imposing on your Sunday, just need to go in tomorrow armed. Best, Eileen
Original Message
From: Eileen Alexanderson
Sent: Wednesday, September 26, 2012 II :08 AM
To: McCaffrey, Carlyn
Subject: please see attached rc our conversation later
Original Message
EFTA_R1_00305006
EFTA01887803
From: NY_730_11_XRX_COPYROOM
[mailto:NY 730 11 XRX [email protected]]
Sent: Wednesday, September 26, 2012 10:56 AM
To: Eileen Alexanderson
Subject: Scan from a Xerox Color
Please open the attached document. It was scanned and sent to you using a Xerox Color.
Number of Images: 4
Attachment File Type: PDF
Device Name: NY 730 II XRX COPYROOM
_
_ _
_
Device Location:
For more information on Xerox products and solutions, please visit http
This email and any files transmitted with it are confidential
and intended solely for the person or entity to whom they are
addressed and may contain confidential and/or privileged
material. Any review, retransmission, dissemination or
other use of, or taking of any action in reliance upon this
information by persons or entities other than the intended
recipient is prohibited. If you have received this email in
error please contact the sender and delete the material from
any computer.
Apollo Global Management, LLC
V V W.XerOX .CO111
*** ***********
**** ********
*********************************
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return c-mail or by c-mail to [email protected], and
EFTA_R1_00305007
EFTA01887804
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA_R1_00305008
EFTA01887805
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.